CN1775253A - Chinese hawthorn blood-pressure-reducing preparation, and new preparing method - Google Patents

Chinese hawthorn blood-pressure-reducing preparation, and new preparing method Download PDF

Info

Publication number
CN1775253A
CN1775253A CNA2005101159891A CN200510115989A CN1775253A CN 1775253 A CN1775253 A CN 1775253A CN A2005101159891 A CNA2005101159891 A CN A2005101159891A CN 200510115989 A CN200510115989 A CN 200510115989A CN 1775253 A CN1775253 A CN 1775253A
Authority
CN
China
Prior art keywords
preparation
active component
soft capsule
chinese medicine
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005101159891A
Other languages
Chinese (zh)
Inventor
刘露
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Fukangren Bio Pharm Tech Co Ltd
Original Assignee
Beijing Fukangren Bio Pharm Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Fukangren Bio Pharm Tech Co Ltd filed Critical Beijing Fukangren Bio Pharm Tech Co Ltd
Priority to CNA2005101159891A priority Critical patent/CN1775253A/en
Publication of CN1775253A publication Critical patent/CN1775253A/en
Pending legal-status Critical Current

Links

Abstract

The present invention relates to a Chinese medicine composition and its preparation process. In particular, it relates to a Chinese medicine prescription for curing hypertension, headache, dizziness, tinnitus and distention in the eyes and its preparation process. Said invention can be made into dripping pills and soft capsule preparation.

Description

Chinese hawthorn blood-pressure-reducing preparation and new preparation method
Technical field:
The present invention relates to a kind of Chinese medicine composition and preparation technology thereof, particularly a kind of vascular hypertension that is used for, it is dizzy to have a headache, prescription and preparation technology thereof that the tinnitus order expands.
Background technology:
Vascular hypertension, it is dizzy to have a headache, and it is clinical common sympton that the tinnitus order expands, and the traditional Chinese medical science is often taked blood pressure lowering, and the means of cholesterol reducing are treated it, and evident in efficacy, and the Chinese hawthorn blood-pressure-reducing ball is that it represents medicine.But in the practice, because this medicine is most of medical material to be beaten powder be used as medicine in preparation, cause impurity many, shortcoming such as dosage is big has a strong impact on its clinical practice.
The preparation of process extraction process preparation of the present invention is easy to dissolving and absorption than elite and thick putting that ordinary pill more can collect medicine, and curative effect is fast, and administration time is short, and therefore, curative effect is better.
The purpose of this invention is to provide a kind of therapeutic domain wide, easily accept, easily absorb, the preparation technology of efficient, low dosage, the Chinese medicine dripping pills that has no side effect, soft capsule, granule, chewable tablet, mixture, its pill that makes can be used for curing mainly vascular hypertension, it is dizzy to have a headache, and the tinnitus order expands.
Summary of the invention:
The present invention relates to a kind of prescription and preparation technology thereof of Chinese medicine preparation, it is characterized in that, the preparation of per 1000 dosage units is prepared from by following proportion raw material:
30~600 parts of 22.5~450 parts of Flos Chrysanthemis of 180~3600 parts of Spica Prunellaes of Fructus Crataegi
30~600 parts of 22.5~450 parts of Semen Cassiaes of 30~600 portions of Rhizoma Alismatis of Herba Cirsii (processed with salt) (stir-fry)
Preferably:
60 parts of 45 parts of Flos Chrysanthemis of 360 parts of Spica Prunellaes of Fructus Crataegi
60 parts of 45 parts of Semen Cassiaes of 60 portions of Rhizoma Alismatis of Herba Cirsii (processed with salt) (stir-fry)
In more than forming, the weight of medicine is calculated with crude drug, and per 1 part can be 1 gram, also can be kilogram or ton, if be unit with gram, this prescription composition can be made into 1000 doses of pharmaceutical preparatioies.Described 1000 doses of fingers, the final drug preparation of making, as make 1000 of soft capsule preparations, drop pill 1000 balls, granule 1000g etc., also can make big packing as granule, as 100~500 bags, specifically can be 100 bags, 125 bags, 200 bags, 250 bags, 500 bags etc., every bag can be used as taking dose 1 time.
More than form, can be made into the preparation of 50~1000 taking doses,, make 125 bags, take 1~2 bag at every turn, can take altogether 62.5~125 times as granule.
More than form to be by weight as proportioning, when producing, can increase or reduce according to corresponding proportion, as large-scale production can be unit with the kilogram, or be unit with the ton, small-scale production can be unit with the milligram also, weight can increase or reduce, but the constant rate of the raw medicinal herbs weight proportion between each composition.
The raw material of Chinese medicine of said ratio extracts processing through new technology of the present invention, obtain the active constituents of medicine of preparation of the present invention, add suitable excipient as required and make suitable medicinal any dosage form, said preparation can be drop pill, soft capsule, granule, chewable tablet, mixture.
The above new technology of the present invention may further comprise the steps:
Method a:(technology 1.)
(1) get Fructus Crataegi, soaked 30~60 minutes earlier with 50~85% ethanol, reheat reflux, extract, 2~5 times, each 0.5~2 hour, merge extractive liquid,, concentrating under reduced pressure became thick extractum;
(2) get the residue medical material, decoct with water 2~4 times, each 0.5~2.5 hour, collecting decoction filtered, and filtrate is condensed into thick paste, promptly gets water extract;
(3) above gained thick paste is merged, add 2~15 times of amount 70~95% ethanol again, stir evenly and leave standstill 6~48h, filter, filtrate decompression concentrates, and is standby.
This active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Method b:(technology 2.)
(1) get the prescription medical material, decoct with water 2~4 times, each 0.5~2.5 hour, collecting decoction filtered, and filtrate is condensed into thick paste, added 2~15 times of amount 70~95% ethanol, stirred evenly and left standstill 6~48h, filtered, and filtrate decompression concentrates, and is standby;
(2) above active component lumps together the active constituents of medicine into preparation of the present invention.
This active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
The active constituents of medicine of the preparation of the present invention that above method obtains can be prepared into preparation of the present invention through further processing.
Preparation of the present invention, different dosage form method difference below is the preparation method of several preferred dosage form.
(1) preparation of drop pill
Drop pill of the present invention, wherein the ratio of active component and adjuvant is 1: 0.5~10, and preferred ratio is 1: 2~4, and most preferred ratio is 1: 3.The above adjuvant be specially molecular weight polyethylene glycol between 400 to 10000 Polyethylene Glycol and their mixture, as PEG400 (PEG400), Macrogol 2000, Macrogol 4000, polyethylene glycol 6000 or their mixture or other suitable other auxiliary elements of making drop pill, as glycerol, gelatin or stearic acid sodium etc.
Following steps are taked in the preparation of drop pill of the present invention:
1. be ready to following raw material: active component, adjuvant and/or other inactive ingredients;
2. with the above-mentioned raw materials mix homogeneously;
3. add the transconversion into heat material, move into the drip irrigation of drop pill machine, medicinal liquid splashes in the liquid sub liquid paraffin by water dropper, removes liquid paraffin, selects ball, promptly.
(2) preparation of soft capsule
Soft capsule preparation of the present invention is that active component and pharmaceutically useful organic solvent and the material of making soft capsule shell are formed.Organic solvent wherein is selected from PEG400, Tween 80, glycerol, propylene glycol, isopropyl alcohol, dehydrogenation soybean oil, vegetable oil, aromatic oil, the material of wherein making soft capsule shell is gelatin or arabic gum, water, plasticizer and antiseptic, the weight ratio of gelatin or arabic gum and plasticizer is 1.0: 0.4~1.0 in the soft capsule shell, and the weight ratio of gelatin and water is 1.0: 0.8~1.2; The content of active component is 50mg~500mg in every soft capsule.
The preparation method of preparation of the present invention, the process following steps:
A. get gelatin, glycerol, pure water adds thermosol, adds an amount of antiseptic, preparation rubber;
B. get active component and be dissolved in organic solvent, add suitable quantity of water, be prepared into soft capsule through encapsulating machine.
(3) preparation process of granule is as follows: with the gained active component, add a certain amount of correctives, filler, lubricant, granulate, promptly get granule.
(4) preparation method of chewable tablet is as follows: with the gained active component, add a certain amount of correctives, filler, lubricant, granulate, and drying, tabletting promptly gets chewable tablet.
Filler described in the preparation of granule, chewable tablet is selected from one or more the mixture in lactose, sucrose, dextrin, starch, microcrystalline Cellulose, mannitol, pregelatinized Starch, sorbitol, the xylitol etc.;
Described correctives one of is selected from Rhizoma et radix valerianae, Fructus Pruni pseudocerasi, Fructus Vitis viniferae, Fructus Citri tangerinae, Fructus Citri Limoniae, Herba Menthae, Fructus Fragariae Ananssae, Fructus Musae, Fructus Ananadis comosi, honey peach essence, maltose alcohol, saccharin sodium, protein sugar, sucrose, aspartame, the stevioside or wherein several mixture;
Suitable lubricant comprises wherein one or more such as magnesium stearate, Pulvis Talci, micropowder silica gel.
Following data declaration beneficial effect of the present invention by experiment:
In order to prove the Clinical feasibility that changes after the technology, we have carried out its main pharmacodynamics, toxicologic study to this medicine, observe its therapeutical effect, and the clinical experimental basis that provides is provided.
1, to the hypertensive influence of rat experiment
Get 32 of healthy rats, be divided into 4 groups (seeing Table 1) at random, 8 every group, survey normotensive value with the rat measuring cell, continuous measurement 3d averages.Every rat subcutaneous injection every day androlin 5mg is total to 10d, and measuring blood pressure 3 times is averaged.Press the listed dosage gastric infusion of table 1, matched group is irritated equal-volume water, and 10d continuously surveys the 4th, 8, the 12d blood pressure then, averages, and sees Table 1.The result shows that each extractum group and matched group comparison can significantly reduce rat blood pressure, see table 1 for details.
The hypertensive influence of table 1 pair rat experiment (x ± s, n=8)
Group Dosage (g/kg) Mean blood pressure (KPa)
Before giving hormone After giving hormone After the administration
Matched group QINGXUAN JIANGYA PIAN technology is 2. extractum group of extractum group technology 1. - 1.2 0.09 0.11 13.8±0.41 14.0±0.42 13.6±0.35 14.1±0.27 17.1±0.65 17.1±0.68 16.9±0.75 17.2±0.55 16.7±0.73 14.1±0.54 ** 13.8±0.56 ** 14.5±0.67 *
Compare with the blank group *P<0.05, *P<0.01 (down together)
2, to the influence of mice autonomic activities
Choose 40 of healthy mices, body weight 16~20g, male and female half and half are divided into 4 groups at random, press the gastric infusion of dosage shown in the table 2, matched group is given equal-volume water, and 5d puts into the autonomic activities analyzer with mice behind the 6d administration 30min continuously, stablize 5min, survey the movable number of times of mice in the 10min, can significantly reduce mice autonomic activities number of times, the results are shown in Table 2.
The influence of table 2 pair mice autonomic activities (x ± s)
Group Number of animals (only) Dosage (g/kg) The autonomic activities number of times
Matched group technology 1. extractum group technology 2. the extractum group is stable 10 10 10 10 - 0.18 0.23 20mg 94.3±23.2 68.4±19.8 ** 69.6±20.1 ** 59.2±15.8 **
3, to the influence of the inductive mouse sleep time of pentobarbital sodium
Get 40 of healthy male mices, grouping and administration experiment 2 together, after last is irritated stomach 30min, press 35mg/kg for each treated animal, the lumbar injection pentobarbital sodium, injection volume is 0.2ml/20g, serves as the sleep index with the mice righting reflex loss, observes and is tried thing to the pentobarbital sodium prolongation effect of the length of one's sleep.The result shows that each extractum group is compared with matched group, and the effect of significant prolongation mouse sleep time is arranged, and shows that Chinese hawthorn blood-pressure-reducing extractum has the sleep of coordination effect.
4, toxicological study
Acute toxicity test shows that rat oral gavage extract of the present invention fails to measure LD 50
Long term toxicity test: rat grouping, extract of the present invention is irritated stomach, every day three times, connect and annotate 90d, the result, administration group rat and control rats movable, search for food, drinking-water, body weight and multinomial observation indexs such as substantial viscera pathologic finding and histopathology detect, result of the test is not all found any toxicity; Hemogram and hepatic and renal function index and the equal no significant difference of matched group.
The blood vessel irritation of this medicine, allergy and hemolytic test all are negative.
In sum, preparation of the present invention, dropping pill formulation particularly of the present invention and soft capsule preparation are a kind of good treatment vascular hypertensions, and it is dizzy to have a headache, the medicine that the tinnitus order expands, and change preparation technology can obviously strengthen its blood pressure lowering, clinical efficacies such as cholesterol reducing, its hypotoxicity in addition, therefore prolonged application safety, be worth clinical application.
The specific embodiment:
Further specify the present invention by the following examples, include but not limited to the following example.
Embodiment 1:
The preparation method of drop pill of the present invention:
Prescription:
Fructus Crataegi 572g Spica Prunellae 72g Flos Chrysanthemi 95g
Herba Cirsii 95g Rhizoma Alismatis (processed with salt) 72g Semen Cassiae (stir-fry) 95g
PEG4000 100g
Make 1000 balls
Preparation method:
(1) get Fructus Crataegi, soaked 60 minutes earlier with 75% ethanol, reheat reflux, extract, 3 times, each 1 hour, merge extractive liquid,, concentrating under reduced pressure became thick extractum;
(2) get the residue medical material, decoct with water 3 times, each 1 hour, collecting decoction filtered, and filtrate is condensed into thick paste;
(3) above gained thick paste is merged, add 7 times of amount 95% ethanol again, stir evenly and leave standstill 12h, filter, filtrate decompression concentrates, and is standby;
(4) with above-mentioned extract obtained, the PEG4000 that adds recipe quantity puts into the vessel in heating dissolving, and jolting makes and dissolves into uniform solution, inserts in the fluid reservoir.Keep 80 ℃ the system of dripping temperature, and a control speed, condensed fluid is a liquid paraffin, drips system promptly.
Embodiment 2:
Preparation of soft capsule method of the present invention:
Prescription:
Fructus Crataegi 2448g Spica Prunellae 306g Flos Chrysanthemi 408g
Herba Cirsii 408g Rhizoma Alismatis (processed with salt) 306g Semen Cassiae (stir-fry) 408g
PEG400 470g
Make 1000
Preparation method:
(1) get Fructus Crataegi, soaked 60 minutes earlier with 75% ethanol, reheat reflux, extract, 3 times, each 1 hour, merge extractive liquid,, concentrating under reduced pressure became thick extractum;
(2) get the residue medical material, decoct with water 3 times, each 1 hour, collecting decoction filtered, and filtrate is condensed into thick paste;
(3) above gained thick paste is merged, add 7 times of amount 95% ethanol again, stir evenly and leave standstill 12h, filter, filtrate decompression concentrates, and is standby.
(4) with above-mentioned extract obtained, add an amount of PEG400 and mix and mixing, add the PEG400 of surplus then, promptly get medicinal liquid.It is standby in addition to join gelatin solution by certain prescription.The condition that control is suitable is regulated content weight, obtains soft capsule in the soft capsule machine.
Embodiment 3:
The preparation method of granule of the present invention:
Prescription:
Fructus Crataegi 3600g Spica Prunellae 450g Flos Chrysanthemi 600g
Herba Cirsii 600g Rhizoma Alismatis (processed with salt) 450g Semen Cassiae (stir-fry) 600g
Make 1000g
Preparation method:
(1) get the prescription medical material, decoct with water 3 times, each 1 hour, collecting decoction filtered, and filtrate is condensed into thick paste, added 5 times of amount 95% ethanol, stirred evenly and left standstill 12h, filtered, and filtrate decompression concentrates, and is standby;
(2) above active component adds aspartame 5.0g, dextrin 200.0g, granulates, and drying sprays into essence 5.0g, promptly gets granule 1000g.
Embodiment 4:
The preparation method of chewable tablet of the present invention:
Prescription:
Fructus Crataegi 1210g Spica Prunellae 151g Flos Chrysanthemi 202g
Herba Cirsii 202g Rhizoma Alismatis (processed with salt) 151g Semen Cassiae (stir-fry) 202g
Make 1000
Preparation method:
(1) get the prescription medical material, decoct with water 3 times, each 1 hour, collecting decoction filtered, and filtrate is condensed into thick paste, added 5 times of amount 95% ethanol, stirred evenly and left standstill 12h, filtered, and filtrate decompression concentrates, and is standby;
(2) above active component adds aspartame 3.0g, mannitol 220.0g, granulation, and drying adds magnesium stearate 3.0g, mixing, and tabletting promptly gets 1000 of chewable tablet.

Claims (10)

1, a kind of Chinese medicine preparation is characterized in that per 1000 dosage units are made by the following weight proportion raw material:
30~600 parts of 22.5~450 parts of Flos Chrysanthemis of 180~3600 parts of Spica Prunellaes of Fructus Crataegi
30~600 parts of 22.5~450 parts of Semen Cassiaes of 30~600 portions of Rhizoma Alismatis of Herba Cirsii (processed with salt) (stir-fry).
2, the compound preparation of claim 1 is characterized in that, per 1000 dosage units are made by the following weight proportion raw material:
60 parts of 45 parts of Flos Chrysanthemis of 360 parts of Spica Prunellaes of Fructus Crataegi
60 parts of 45 parts of Semen Cassiaes of 60 portions of Rhizoma Alismatis of Herba Cirsii (processed with salt) (stir-fry).
3, claim 1 or any one Chinese medicine preparation of 2 are drop pill, soft capsule, granule, chewable tablet, mixture.
4, the Chinese medicine preparation of claim 3 through described raw material is extracted processing, obtains active component, adds suitable adjuvant as required and makes.
5, the Chinese medicine preparation of claim 4 is characterized in that, described active component prepares through following steps:
Method a:(technology 1.)
(1) get Fructus Crataegi, soaked 30~60 minutes earlier with 50~85% ethanol, reheat reflux, extract, 2~5 times, each 0.5~2 hour, merge extractive liquid,, concentrating under reduced pressure became thick extractum;
(2) get the residue medical material, decoct with water 2~4 times, each 0.5~2.5 hour, collecting decoction filtered, and filtrate is condensed into thick paste, promptly gets water extract;
(3) above gained thick paste is merged, add 2~15 times of amount 70~95% ethanol again, stir evenly and leave standstill 6~48h, filter, filtrate decompression concentrates, and is standby.
This active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Method b:(technology 2.)
(1) get the prescription medical material, decoct with water 2~4 times, each 0.5~2.5 hour, collecting decoction filtered, and filtrate is condensed into thick paste, added 2~15 times of amount 70~95% ethanol, stirred evenly and left standstill 6~48h, filtered, and filtrate decompression concentrates, and is standby.
(2) above active component lumps together the active constituents of medicine into preparation of the present invention.
This active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
6, the Chinese medicine preparation of claim 5 is characterized in that:
Described drop pill, wherein the ratio of active component and adjuvant is 1: 0.5~10, described adjuvant be molecular weight between 400 to 10000 Polyethylene Glycol and their mixture, be selected from PEG400 (or 600), Macrogol 2000, Macrogol 4000, polyethylene glycol 6000 or their mixture.
Its preparation method is: active constituents of medicine and proper auxiliary materials behind 60~115 ℃ of mix homogeneously, are regulated the water dropper size with control drop pill weight, are that the coolant system of dripping forms with dimethicone or liquid paraffin, and coolant temperature is-10~5 ℃.
7, the Chinese medicine preparation of claim 5 is characterized in that:
Described soft capsule, its content is made up of active component and suitable substrate, and wherein the content of active component is 50mg~500mg in every soft capsule; Substrate wherein is selected from wherein one or more of PEG400, Tween 80, glycerol, propylene glycol, isopropyl alcohol, dehydrogenation soybean oil, vegetable oil, aromatic oil, animal wet goods.
Its preparation method is: with active constituents of medicine and proper auxiliary materials mix homogeneously, obtain uniform suspension and/or solution, regulate content weight, compacting, dry getting final product.
8, the Chinese medicine preparation of claim 5 is characterized in that:
The preparation process of described granule is as follows: with above-mentioned extract obtained, add a certain amount of filler, correctives, lubricant, granulate, promptly get granule;
The preparation method of chewable tablet is as follows: with above-mentioned extract obtained, adds a certain amount of filler, correctives, lubricant, granulates, and drying, tabletting promptly gets chewable tablet.
9, the Chinese medicine preparation of claim 8 is characterized in that:
Described filler is selected from one or more the mixture in lactose, sucrose, dextrin, starch, microcrystalline Cellulose, mannitol, pregelatinized Starch, sorbitol, the xylitol etc.;
Described correctives one of is selected from Rhizoma et radix valerianae, Fructus Pruni pseudocerasi, Fructus Vitis viniferae, Fructus Citri tangerinae, Fructus Citri Limoniae, Herba Menthae, Fructus Fragariae Ananssae, Fructus Musae, Fructus Ananadis comosi, honey peach essence, maltose alcohol, saccharin sodium, protein sugar, sucrose, aspartame, the stevioside or wherein several mixture;
Suitable lubricant comprises wherein one or more such as magnesium stearate, Pulvis Talci, micropowder silica gel.
10, the preparation method of any one Chinese medicine preparation of claim 1~9 is characterized in that, the process following steps:
Described raw material of Chinese medicine is extracted processing, obtain active component, add suitable adjuvant and make; Wherein said active component prepares through following steps:
Method a:(technology 1.)
(1) get Fructus Crataegi, soaked 30~60 minutes earlier with 50~85% ethanol, reheat reflux, extract, 2~5 times, each 0.5~2 hour, merge extractive liquid,, concentrating under reduced pressure became thick extractum;
(2) get the residue medical material, decoct with water 2~4 times, each 0.5~2.5 hour, collecting decoction filtered, and filtrate is condensed into thick paste, promptly gets water extract;
(3) above gained thick paste is merged, add 2~15 times of amount 70~95% ethanol again, stir evenly and leave standstill 6~48h, filter, filtrate decompression concentrates, and is standby.
This active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Method b:(technology 2.)
(1) get the prescription medical material, decoct with water 2~4 times, each 0.5~2.5 hour, collecting decoction filtered, and filtrate is condensed into thick paste, added 2~15 times of amount 70~95% ethanol, stirred evenly and left standstill 6~48h, filtered, and filtrate decompression concentrates, and is standby.
(2) above active component lumps together the active constituents of medicine into preparation of the present invention.
This active component is suitable for preparing various preparations such as drop pill of the present invention and soft capsule.
Described drop pill, wherein the ratio of active component and adjuvant is 1: 0.5~10, described adjuvant be molecular weight between 400 to 10000 Polyethylene Glycol and their mixture, be selected from PEG400 (or 600), Macrogol 2000, Macrogol 4000, polyethylene glycol 6000 or their mixture.
Its preparation method is: active constituents of medicine and proper auxiliary materials behind 60~115 ℃ of mix homogeneously, are regulated the water dropper size with control drop pill weight, are that the coolant system of dripping forms with dimethicone or liquid paraffin, and coolant temperature is-10~5 ℃.
Described soft capsule, its content is made up of active component and suitable substrate, and wherein the content of active component is 50mg~500mg in every soft capsule; Substrate wherein is selected from wherein one or more of PEG400, Tween 80, glycerol, propylene glycol, isopropyl alcohol, dehydrogenation soybean oil, vegetable oil, aromatic oil, animal wet goods.
Its preparation method is: active constituents of medicine is mixed with proper auxiliary materials, obtain uniform suspension and/or solution, regulate content weight, compacting, dry getting final product.
CNA2005101159891A 2005-11-18 2005-11-18 Chinese hawthorn blood-pressure-reducing preparation, and new preparing method Pending CN1775253A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2005101159891A CN1775253A (en) 2005-11-18 2005-11-18 Chinese hawthorn blood-pressure-reducing preparation, and new preparing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2005101159891A CN1775253A (en) 2005-11-18 2005-11-18 Chinese hawthorn blood-pressure-reducing preparation, and new preparing method

Publications (1)

Publication Number Publication Date
CN1775253A true CN1775253A (en) 2006-05-24

Family

ID=36765052

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005101159891A Pending CN1775253A (en) 2005-11-18 2005-11-18 Chinese hawthorn blood-pressure-reducing preparation, and new preparing method

Country Status (1)

Country Link
CN (1) CN1775253A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101972368A (en) * 2010-10-28 2011-02-16 赤峰天奇制药有限责任公司 Process for preparing chrysanthemum pressure-reducing granules
CN102670769A (en) * 2011-03-18 2012-09-19 李启辉 Tea lowering blood pressure and enabling all natural plants to serve as formula and preparation method thereof
CN103908539B (en) * 2014-05-03 2017-02-01 李全浩 Traditional Chinese medicine composition for treating hypertension as well as preparation method and application of traditional Chinese medicine composition
CN108614065A (en) * 2016-12-09 2018-10-02 内蒙古天奇中蒙制药股份有限公司 A kind of method of quality control of mountain chrysanthemum Jiangya Granula
CN112022939A (en) * 2020-09-01 2020-12-04 南京同仁堂药业有限责任公司 Capsule for treating hypertension complicated with hyperlipidemia and preparation method thereof
CN116808119A (en) * 2023-03-29 2023-09-29 南京同仁堂药业有限责任公司 Mountain chrysanthemum antihypertensive capsule and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101972368A (en) * 2010-10-28 2011-02-16 赤峰天奇制药有限责任公司 Process for preparing chrysanthemum pressure-reducing granules
CN102670769A (en) * 2011-03-18 2012-09-19 李启辉 Tea lowering blood pressure and enabling all natural plants to serve as formula and preparation method thereof
CN103908539B (en) * 2014-05-03 2017-02-01 李全浩 Traditional Chinese medicine composition for treating hypertension as well as preparation method and application of traditional Chinese medicine composition
CN108614065A (en) * 2016-12-09 2018-10-02 内蒙古天奇中蒙制药股份有限公司 A kind of method of quality control of mountain chrysanthemum Jiangya Granula
CN112022939A (en) * 2020-09-01 2020-12-04 南京同仁堂药业有限责任公司 Capsule for treating hypertension complicated with hyperlipidemia and preparation method thereof
CN116808119A (en) * 2023-03-29 2023-09-29 南京同仁堂药业有限责任公司 Mountain chrysanthemum antihypertensive capsule and preparation method thereof

Similar Documents

Publication Publication Date Title
CN1943610A (en) Chinese medicine preparation for traumatic injury and blood stasis and swelling pain
CN1824240A (en) Shenshu Jianpi medicinal preparation for invigorating spleen and its new preparation method
CN1748774A (en) Brain tonifying preparation and new preparing method
CN1775253A (en) Chinese hawthorn blood-pressure-reducing preparation, and new preparing method
CN1775261A (en) Mingmu-Dihuang preparation and new preparing method
CN1824101A (en) Xingsuerchen medicinal preparation and its new preparation method
CN1775262A (en) Guifu-Dihuang preparation and preparing method
CN1748748A (en) Little leaf deervetch herb preparation for pregnant woman and new preparing method
CN1824018A (en) Dual supplementation preparation of qi and blood and its making method
CN1775246A (en) Preparation for treating breast sore and new preparing method
CN1775264A (en) Maiwei-dihuang preparation and new preparing method
CN1775263A (en) Qiju-dihuang preparation and new preparation method
CN1824016A (en) Compound flowery knotweed and rehmannia preparation and its manufacturing method
CN1850264A (en) Safflower preparation for treating wound and new preparing method
CN1775238A (en) Anti-inflammtory anti-dysentery preparation and new preparing method
CN1843440A (en) Traditional Chinese medicine formulation and its novel preparation method
CN1824113A (en) Postpartum laonurus medicinal preparation and its new preparation method
CN1943694A (en) A Chinese traditional medicinal composition for treating renal deficiency, edema, lumbago and gonalgia, etc.
CN1824109A (en) Liaoyuanqili medicinal preparation and its new preparation method
CN1824099A (en) Diffusing-freeing lung rectifying medicinal preparation and its new preparation method
CN1775248A (en) Dried tangerine peel sputum-resolving preparation and new preparing method
CN1824128A (en) Semen locking medicinal preparation and its new preparation method
CN1775258A (en) Womb-warming pregnancy-aiding preparation and new preparing method
CN1775244A (en) Blood-cleaning detoxifying formulation and new preparing method
CN1824014A (en) Blood pressure reducing preparation and its making method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication